Compositional profiling and molecular docking studies of Eucalyptus polybrachtea essential oil against mucormycosis and aspergillosis

Essential oil (EO) from Eucalyptus polybrachtea is used as complementary and traditional medicine worldwide. The present study aimed at compositional profiling of EO and molecular docking of EO’s bioactive compound 1,8 cineole against fungal enzymes involved in the riboflavin synthesis pathway, na...

Full description

Bibliographic Details
Published in:	BioTechnologia
Main Authors:	Arun Dev Sharma, Inderjeet Kaur, Amrita Chauhan
Format:	Article
Language:	English
Published:	Termedia Publishing House 2023-09-01
Subjects:	aspergillosis mucormycosis eucalyptus oil herbal drug
Online Access:	https://www.termedia.pl/Compositional-profiling-and-molecular-docking-studies-r-nof-Eucalyptus-polybrachtea-essential-oil-r-nagainst-mucormycosis-and-aspergillosis,85,51300,1,1.html

Similar Items

Anti-aspergillosis and anti-mucormycosis potential of essential oils from two Cymbopogon spp. targeting riboflavin synthesis pathway
by: Arun Dev Sharma, et al.
Published: (2023-05-01)

Targeting H3N2 Influenza Virus RNA-dependent RNA Polymerase by Using Bioactives from Essential Oils from Eucalyptus polybrachtea, Cymbopogon citratus and Cymbopogon khasianus
by: Arun Dev Sharma, et al.
Published: (2023-09-01)

Molecular docking studies of principal components and in vitro inhibitory activities of Rosmarinus officinalis essential oil against Aspergillus flavus, Aspergillus fumigatus and Mucor indicus
by: Arun Dev Sharma, et al.
Published: (2023-11-01)

Chemical profiling and in-vitro anti-oxidant, anti-diabetic, anti-inflammatory, anti-bacterial and anti-fungal activities of essential oil from Rosmarinus officinalis L.
by: Arun D. SHARMA, et al.
Published: (2024-03-01)

Management of mucormycosis coexisting with aspergillosis in pediatric age group – a case report
by: Ashish Gopal, et al.
Published: (2023-05-01)

Oral Mucormycosis and Aspergillosis in the Patient with Acute Leukemia
by: Vanja Vučićević Boras, et al.
Published: (2019-01-01)

INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-07-01)

Dual Disseminated Aspergillosis and Mucormycosis Diagnosed at Autopsy: A Report of Two Cases of Coinfection and a Review of the Literature
by: Jason Murray, et al.
Published: (2023-03-01)

Salvage Treatment for Invasive Aspergillosis and Mucormycosis: Challenges, Recommendations and Future Considerations
by: Egger M, et al.
Published: (2023-04-01)

A fatal case report of invasive pulmonary aspergillosis and mucormycosis coinfection in an immunocompetent patient with coronavirus disease 2019 in Korea
by: Jin Hyoung Kim, et al.
Published: (2023-08-01)

COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis
by: Shiang-Fen Huang, et al.
Published: (2023-06-01)

Rhino-Orbital Mucormycosis and Aspergillosis in A Child With Thalassemia Major on Deferoxamine Therapy
by: Siddharth Madan, et al.
Published: (2021-01-01)

Nanomaterial-Based Antifungal Therapies to Combat Fungal Diseases Aspergillosis, Coccidioidomycosis, Mucormycosis, and Candidiasis
by: Angel León-Buitimea, et al.
Published: (2021-10-01)

Comparative risk assessment of COVID‐19 associated mucormycosis and aspergillosis: A systematic review
by: Prodip Kumar Baral, et al.
Published: (2022-09-01)

COMBINATION OF INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-02-01)

Dual Fungal Infection of Aspergillosis and Mucormycosis in a COVID-19 Patient: A Rare Case Report
by: Nikhil, et al.
Published: (2022-12-01)

Cerebro-rhino-orbital mucormycosis and aspergillosis coinfection in a patient with diabetes mellitus: A case report
by: Souheil Zayet, et al.
Published: (2021-01-01)

COVID-19-associated rhino-mucormycosis and pulmonary aspergillosis infection
by: Jitender Singh, et al.
Published: (2022-01-01)

Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
by: Natesan SK, et al.
Published: (2016-12-01)

A critical appraisal of mucormycosis in COVID- 19 patients in a tertiary care centre in India
by: Sujata Raychaudhuri, et al.
Published: (2023-03-01)

COVID-19-associated mucormycosis – “The Black fungus” with associated invasive aspergillosis and actinomycosis infection: Series of 5 cases in the Indian scenario
by: Reetika Menia, et al.
Published: (2023-01-01)

Use of Antifungals and Outcomes Among Inpatients at Risk of Invasive Aspergillosis or Mucormycosis in the USA: A Retrospective Cohort Study
by: Katherine Stull, et al.
Published: (2019-10-01)

Dental and Oral Manifestations of COVID-19 Related Mucormycosis: Diagnoses, Management Strategies and Outcomes
by: Omer Sefvan Janjua, et al.
Published: (2021-12-01)

Chemical Profile and in-silico Docking Studies on Bioactives from Essential Oil of Cymbopogan pendulus Targeting Penicillin Binding Proteins (PBPs) in Bacteria
by: Arun Dev Sharma, et al.
Published: (2023-02-01)

Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
by: Lefteris Floros, et al.
Published: (2019-02-01)

Antibacterial, Antioxidant, and Antiproliferative Activities of Corymbia citriodora and the Essential Oils of Eight Eucalyptus Species
by: Maria Graça Miguel, et al.
Published: (2018-06-01)

Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis
by: Alexandra Serris, et al.
Published: (2022-06-01)

Chemical composition of essential oils from Eucalyptus globulus and Eucalyptus maculata grown in Tanzania
by: Ismail Almas, et al.
Published: (2021-07-01)

Formulation and evaluation of Chinese eucalyptus oil gel by using different gelling agents as an antimicrobial agent
by: Deepshikha Dubey, et al.
Published: (2023-12-01)

Colonic Mucormycosis In A Post Covid Patient: A Case Report
by: Amrita Patkar, et al.
Published: (2023-08-01)

Hemorrhagic Fever with Renal Syndrome Complicated with Rhino Mucormycosis: A Case Report
by: Guo L, et al.
Published: (2022-12-01)

Bio-active components of Cymbopogon martinii essential oil as therapeutics targeting bacterial Penicillin-Binding-Proteins (PBPs): Aroma profile, in silico-docking, pharmacokinetics, and wet-lab validation
by: Amrita Chauhan, et al.
Published: (2023-07-01)

Invasive Fungal Infections Associated with COVID-19
by: Kyaw M. Hlaing, et al.
Published: (2023-06-01)

Predisposing factors of mycotic infections in COVID-19 patients
by: Satyam Singh, et al.
Published: (2022-01-01)

Unusual presentation of mucormycosis
by: Sanjiv Saxena, et al.
Published: (2016-01-01)

Cytotoxic effects of different solvents and essential oil of eucalyptus on human fibroblast cells
by: S. Samavati, et al.
Published: (2015-12-01)

Rhino-orbital mucormycosis
by: S.D. Mathebula
Published: (2006-12-01)

Mucormycosis of the Mandible and Tongue: A Systematic Scoping Review
by: Kausar Sadia Fakhruddin, et al.
Published: (2024-06-01)

Bio-active components of Melaleuca alternifolia, Rosmarinus officinalis, Boswellia serrata essential oil as anti-diabetic therapeutics targeting α-amylase : In-vitro α-amylase inhibition, antioxidant, binding interaction, and docking studies of predominan
by: Arun Dev Sharma, et al.
Published: (2024-07-01)

Radiological findings of mucormycosis rhinosinusitis among Indian COVID-19 patients during the pandemic second wave
by: Roger Anthony Manuel, et al.
Published: (2023-06-01)